Hammock BD - Search Results

1

Effect Of Dual sEH/COX-2 Inhibition on Allergen-Induced Airway Inflammation.

Dileepan M, Rastle-Simpson S, Greenberg Y, Wijesinghe DS, Kumar NG, Yang J, Hwang SH, Hammock BD, Sriramarao P, Rao SP. Dileepan M, et al. Among authors: hammock bd. Front Pharmacol. 2019 Sep 27;10:1118. doi: 10.3389/fphar.2019.01118. eCollection 2019. Front Pharmacol. 2019. PMID: 31611798 Free PMC article.

2

Cellular characterization of leukotoxin diol-induced mitochondrial dysfunction.

Sisemore MF, Zheng J, Yang JC, Thompson DA, Plopper CG, Cortopassi GA, Hammock BD. Sisemore MF, et al. Among authors: hammock bd. Arch Biochem Biophys. 2001 Aug 1;392(1):32-7. doi: 10.1006/abbi.2001.2434. Arch Biochem Biophys. 2001. PMID: 11469791

3

Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors.

Hwang SH, Morisseau C, Do Z, Hammock BD. Hwang SH, et al. Among authors: hammock bd. Bioorg Med Chem Lett. 2006 Nov 15;16(22):5773-7. doi: 10.1016/j.bmcl.2006.08.078. Epub 2006 Sep 1. Bioorg Med Chem Lett. 2006. PMID: 16949285 Free PMC article.

4

Orally bioavailable potent soluble epoxide hydrolase inhibitors.

Hwang SH, Tsai HJ, Liu JY, Morisseau C, Hammock BD. Hwang SH, et al. Among authors: hammock bd. J Med Chem. 2007 Aug 9;50(16):3825-40. doi: 10.1021/jm070270t. Epub 2007 Jul 6. J Med Chem. 2007. PMID: 17616115 Free PMC article.

5

Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation.

Liu JY, Tsai HJ, Hwang SH, Jones PD, Morisseau C, Hammock BD. Liu JY, et al. Among authors: hammock bd. Br J Pharmacol. 2009 Jan;156(2):284-96. doi: 10.1111/j.1476-5381.2008.00009.x. Epub 2009 Jan 13. Br J Pharmacol. 2009. PMID: 19154430 Free PMC article.

6

Alteration in plasma testosterone levels in male mice lacking soluble epoxide hydrolase.

Luria A, Morisseau C, Tsai HJ, Yang J, Inceoglu B, De Taeye B, Watkins SM, Wiest MM, German JB, Hammock BD. Luria A, et al. Among authors: hammock bd. Am J Physiol Endocrinol Metab. 2009 Aug;297(2):E375-83. doi: 10.1152/ajpendo.00131.2009. Epub 2009 May 19. Am J Physiol Endocrinol Metab. 2009. PMID: 19458064 Free PMC article.

7

Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile in vivo.

Liu JY, Park SH, Morisseau C, Hwang SH, Hammock BD, Weiss RH. Liu JY, et al. Among authors: hammock bd. Mol Cancer Ther. 2009 Aug;8(8):2193-203. doi: 10.1158/1535-7163.MCT-09-0119. Epub 2009 Aug 11. Mol Cancer Ther. 2009. PMID: 19671760 Free PMC article.

8

Quantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometry.

Yang J, Schmelzer K, Georgi K, Hammock BD. Yang J, et al. Among authors: hammock bd. Anal Chem. 2009 Oct 1;81(19):8085-93. doi: 10.1021/ac901282n. Anal Chem. 2009. PMID: 19715299 Free PMC article.

9

Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches.

Li N, Liu JY, Timofeyev V, Qiu H, Hwang SH, Tuteja D, Lu L, Yang J, Mochida H, Low R, Hammock BD, Chiamvimonvat N. Li N, et al. Among authors: hammock bd. J Mol Cell Cardiol. 2009 Dec;47(6):835-45. doi: 10.1016/j.yjmcc.2009.08.017. Epub 2009 Aug 28. J Mol Cell Cardiol. 2009. PMID: 19716829 Free PMC article.

10

Inhibition of soluble epoxide hydrolase by trans-4- [4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury.

Chaudhary KR, Abukhashim M, Hwang SH, Hammock BD, Seubert JM. Chaudhary KR, et al. Among authors: hammock bd. J Cardiovasc Pharmacol. 2010 Jan;55(1):67-73. doi: 10.1097/FJC.0b013e3181c37d69. J Cardiovasc Pharmacol. 2010. PMID: 19834332 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,108 results

Search Page